Table 3.

Overall survival: univariate analysis of prognostic clinicopathologic factors

	3-yr survival (%)	5-yr survival (%)	P-value
Age (yr)
≤ 65	52.8	34.2	0.24
> 65	63.1	52.0
Gender
Male	56.1	38.4	0.41
Female	60.6	50.0
Cirrhosis
Yes	35.0	12.3	0.03
No	60.6	47.9
Serum AFP (ng/mL)
≤ 200	55.9	34.6	0.57
> 200	55.4	45.5
Tumor location
Spiegel lobe	63.1	45.7	0.01
Paracaval portion	22.9	16.2
Caudate process	25.2	14.9
Tumor size (cm)
≤ 5	58.4	43.3	0.48
> 5	57.0	39.4
Pringle maneuver
No	67.7	42.1	0.73
Yes	62.5	37.9
Surgical margin (mm)
≤ 5	20.4	18.5	0.02
> 5	60.7	54.6
Surgical treatment
Isolated caudate lobectomy	52.1	42.1	0.04
Extended hepatectomy	27.9	15.4
Histologic grading
Differentiated	57.7	33.6	0.79
Undifferentiated	52.2	29.4
Capsule
No	65.3	41.5	0.70
Yes	56.1	35.9
Vascular invasion
No	52.4	37.9	0.05
Yes	29.2	23.2
Daughter nodules
No	56.1	36.8	0.38
Yes	45.3	25.0